Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 2/20 | 0.56 |
| ▸ | HTR3A | P46098 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | AURKA | O14965 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MASP2 | O00187 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4107024 | 0.84 | BCHE (0.49) | BCHEACHEHTR3ATP53RAB9A | |
| SCHEMBL9554794 | 0.78 | BCHE (0.54) | BCHEACHEHTR3ATP53RAB9A | |
| SCHEMBL7018102 | 0.78 | BCHE (0.50) | BCHEACHEHTR3ATP53RAB9A | |
| SCHEMBL546101 | 0.78 | EGLN1 (0.51) | BCHEACHEHTR3ATP53RAB9A | |
| SCHEMBL8190392 | 0.77 | AURKA (0.42) | BCHEACHERAB9AALDH1A1AURKA | |
| SCHEMBL28203123 | 0.77 | EGLN1 (0.37) | BCHEACHETP53RAB9AKDM4E | |
| SCHEMBL15190212 | 0.77 | AURKA (0.53) | BCHEACHEHTR3ATP53RAB9A | |
| SCHEMBL28790670 | 0.77 | BCHE (0.42) | BCHEACHEHTR3ATP53RAB9A | |
| SCHEMBL23441765 | 0.75 | KDM4E (0.51) | BCHEACHEHTR3ATP53RAB9A | |
| SCHEMBL19520508 | 0.74 | HTR3A (0.57) | HTR3ARAB9AKDM4EALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108440538-B | Novel pyrroloimidazole derivative and preparation method and application thereof | 上海工程技术大学 | 2021-03-16 | — | — | CN | claimed |
| CN-110563938-B | Polyether copolymer, crosslinkable polyether copolymer composition, electrolyte, and composite | 日本瑞翁株式会社 | 2022-07-22 | — | — | CN | disclosed |
| CN-112703219-A | Polyether compound and gas separation membrane | 日本瑞翁株式会社 | 2021-04-23 | — | — | CN | disclosed |
| CN-108440538-B | Novel pyrroloimidazole derivative and preparation method and application thereof | 上海工程技术大学 | 2021-03-16 | — | — | CN | disclosed |
| CN-108440538-B | Novel pyrroloimidazole derivative and preparation method and application thereof | 上海工程技术大学 | 2021-03-16 | — | — | CN | disclosed |
| CN-110563938-A | Polyether copolymer, crosslinkable polyether copolymer composition, electrolyte, and composite | 日本瑞翁株式会社 | 2019-12-13 | — | — | CN | disclosed |
| CN-110447135-A | Composite polymer electrolyte film | ASAHI CHEMICAL IND | 2019-11-12 | — | — | CN | disclosed |
| CN-108840824-A | The preparation process of 4- phenyl cycloheptylamine | 遵义医学院附属医院 | 2018-11-20 | — | — | CN | disclosed |
| US-20100113524-A1 | Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety | ALEVIUM PHARMACEUTICALS, INC. | 2010-05-06 | — | — | US | disclosed |
| US-20100113524-A1 | Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety | ALEVIUM PHARMACEUTICALS, INC. | 2010-05-06 | — | — | US | disclosed |
| EP-2102191-A1 | CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE | IL YANG PHARMACEUTICAL COMPANY, LTD. (KR) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008083341-A1 | CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE | IL YANG PHARMACEUTICAL COMPANY, LTD. (KR) | 2008-07-10 | — | — | WO | disclosed |
| WO-2008036211-A1 | PRODRUGS OF PROTON PUMP INHIBITORS INCLUDING THE (1H-PYRROL-1-YL)-1H-BENZIMIDAZOLE MOIETY | ALEVIUM PHARMACEUTICALS, INC. (US) | 2008-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113524-A1 | Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety | ABCB11, ATP6AP1, PAH | BCHE 3253/4885ACHE 3789/4885HTR3A 1626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.